Accordingly, NME1 and NME2 are overexpressed early in the primary tumor and only NME1 expression is reduced or repressed at later stages in colorectal and hepatic tumors that have undergone metastasis [43, 60, 84]. The gene discussed is NME2; the disease is neoplasm.